Haruka Uezono

588 total citations
24 papers, 384 citations indexed

About

Haruka Uezono is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Haruka Uezono has authored 24 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 7 papers in Rheumatology. Recurrent topics in Haruka Uezono's work include Sarcoma Diagnosis and Treatment (7 papers), Bone Tumor Diagnosis and Treatments (6 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Haruka Uezono is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Bone Tumor Diagnosis and Treatments (6 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Haruka Uezono collaborates with scholars based in United States, Japan and Netherlands. Haruka Uezono's co-authors include Daniel J. Indelicato, Ronny L. Rotondo, Christopher G. Morris, Julie A. Bradley, Ryohei Sasaki, Eric Sandler, Philipp R. Aldana, Nathan J. Ranalli, Toshinori Soejima and Hiroshi Mayahara and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, British Journal of Radiology and Acta Oncologica.

In The Last Decade

Haruka Uezono

22 papers receiving 382 citations

Peers

Haruka Uezono
Christopher Biggs United States
Fatih Özcan Türkiye
Esin Gündem Türkiye
Waqar Haque United States
Yelda Elcim Türkiye
R.J. McCammon United States
Beat Bojaxhiu Switzerland
Haruka Uezono
Citations per year, relative to Haruka Uezono Haruka Uezono (= 1×) peers Yoshihito Nomoto

Countries citing papers authored by Haruka Uezono

Since Specialization
Citations

This map shows the geographic impact of Haruka Uezono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruka Uezono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruka Uezono more than expected).

Fields of papers citing papers by Haruka Uezono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruka Uezono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruka Uezono. The network helps show where Haruka Uezono may publish in the future.

Co-authorship network of co-authors of Haruka Uezono

This figure shows the co-authorship network connecting the top 25 collaborators of Haruka Uezono. A scholar is included among the top collaborators of Haruka Uezono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruka Uezono. Haruka Uezono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Uezono, Haruka, Kayoko Tsujino, Shuhei Sekii, et al.. (2022). CT-based image-guided brachytherapy in uterine cervical cancer: Effect of tumor dose and volume on local control. Brachytherapy. 21(6). 814–822. 3 indexed citations
3.
Dagan, Roi, Haruka Uezono, Curtis Bryant, et al.. (2021). Long-term Outcomes from Proton Therapy for Sinonasal Cancers. International Journal of Particle Therapy. 8(1). 200–212. 12 indexed citations
4.
Uezono, Haruka, et al.. (2021). Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University. Nuclear Medicine Communications. 42(11). 1277–1284. 2 indexed citations
5.
Uezono, Haruka, David Nam, Harriet M. Kluger, et al.. (2021). Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases. American Journal of Clinical Oncology. 44(9). 495–501. 12 indexed citations
6.
Indelicato, Daniel J., Ronny L. Rotondo, Matthew J. Krasin, et al.. (2020). Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma. International Journal of Radiation Oncology*Biology*Physics. 106(5). 968–976. 11 indexed citations
7.
Uezono, Haruka, Daniel J. Indelicato, Ronny L. Rotondo, et al.. (2020). Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis. International Journal of Radiation Oncology*Biology*Physics. 107(5). 974–981. 21 indexed citations
8.
Bradley, Julie A., Daniel J. Indelicato, Haruka Uezono, et al.. (2020). Patterns of Failure in Parameningeal Alveolar Rhabdomyosarcoma. International Journal of Radiation Oncology*Biology*Physics. 107(2). 325–333. 9 indexed citations
9.
Indelicato, Daniel J., Ronny L. Rotondo, Haruka Uezono, et al.. (2019). Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma. International Journal of Radiation Oncology*Biology*Physics. 104(1). 149–156. 88 indexed citations
10.
Hol, M., Daniel J. Indelicato, Ronny L. Rotondo, et al.. (2019). Dose-Effect Analysis of Early Changes in Orbital Bone Morphology After Radiation Therapy for Rhabdomyosarcoma. Practical Radiation Oncology. 10(1). 53–58. 6 indexed citations
11.
Nakamura, Masaki, Ryo Nishikawa, Hiroshi Mayahara, et al.. (2019). Pattern of recurrence after CyberKnife stereotactic body radiotherapy for peripheral early non-small cell lung cancer. Journal of Thoracic Disease. 11(1). 214–221. 11 indexed citations
12.
Indelicato, Daniel J., Ronny L. Rotondo, Raymond B. Mailhot Vega, et al.. (2019). 45 GyRBE for group III orbital embryonal rhabdomyosarcoma. Acta Oncologica. 58(10). 1404–1409. 5 indexed citations
13.
Indelicato, Daniel J., Ronny L. Rotondo, Raymond B. Mailhot Vega, et al.. (2019). Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base. Pediatric Blood & Cancer. 67(2). e28080–e28080. 17 indexed citations
14.
Indelicato, Daniel J., Ronny L. Rotondo, Raymond B. Mailhot Vega, et al.. (2019). Outcomes Following Proton Therapy for Ewing Sarcoma of the Cranium and Skull Base. International Journal of Radiation Oncology*Biology*Physics. 105(1). E635–E635.
15.
Nakamura, Masaki, Naoki Hashimoto, Hiroshi Mayahara, et al.. (2018). Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence. Radiation Oncology. 13(1). 75–75. 8 indexed citations
16.
Nakamura, Masaki, Hideki Nishimura, Hiroshi Mayahara, et al.. (2017). Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: ‘symptomatic control’. Journal of Radiation Research. 58(6). 834–839. 9 indexed citations
18.
Nakamura, Masaki, Hideki Nishimura, Masao Nakayama, et al.. (2016). Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer. British Journal of Radiology. 89(1068). 20160560–20160560. 28 indexed citations
19.
Uezono, Haruka, et al.. (2013). Pelvic insufficiency fracture after definitive radiotherapy for uterine cervical cancer: retrospective analysis of risk factors. Journal of Radiation Research. 54(6). 1102–1109. 63 indexed citations
20.
Tamaki, Yukihisa, Akira Sano, Takuya Okada, et al.. (2007). Bilateral popliteal artery entrapment syndrome: reemphasis on reading axial tomograms. Radiation Medicine. 25(10). 548–552. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026